Clinical trial
Belatacept in De Novo Heart Transplantation - Pilot Study
NCT04477629 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Belatacept in De Novo Heart Transplantation - Pilot Study
- Lead sponsor
- NYU Langone Health
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- August 6, 2020
- Completion date
- September 30, 2026
- Enrollment
- 12 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
heart transplantation